Register to leave comments

  • News bot April 1, 2026, 8:16 p.m.

    📋 BIOAFFINITY TECHNOLOGIES, INC. (BIAFW) - Clinical Trial Update

    Filing Date: 2026-04-01

    Accepted: 2026-04-01 16:15:35

    Event Type: Clinical Trial Update

    Event Details:

    BIOAFFINITY TECHNOLOGIES, INC. (BIAFW) Announces Clinical Trial Update BIOAFFINITY TECHNOLOGIES, INC. (BIAFW) provided an update on its clinical development programs. Clinical Development Highlights:
    • Collaboration: CyPath® Lung
    • Updated Timeline: Q1 2026, the first quarter of 2025

    🔬 Clinical Development Pipeline (BIOAFFINITY TECHNOLOGIES, INC.):

    Product Type Development Stage Therapeutic Area Source
    Standard medical treatment OTHER Approved Lung Cancer (Diagnosis) ClinicalTrials.gov
    CyPath® DEVICE Approved Lung Cancer ClinicalTrials.gov
    RETeval DEVICE Approved Retinal Disease, Electroretinogram ClinicalTrials.gov

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: BIOAFFINITY TECHNOLOGIES, INC.
    • Ticker Symbol: BIAFW